FindTrial
Sign In

ââ?¬Å?COMPARISON OF PROPOFOL AND ETOMIDATE -TWO INTRAVENOUS ANAESTHETIC AGENTS TO ASSESS STRESS RESPONSE TO LARYNGOSCOPY AND ENDOTRACHEAL INTUBATIONââ?¬?

ââ?¬Å?COMPARISON OF PROPOFOL VS ETOMIDATE AS AN INDUCTION AGENT TO EVALUATE HEMODYNAMIC RESPONSE TO LARYNGOSCOPY AND ENDOTRACHEAL INTUBATIONââ?¬?

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045366
Enrollment
60
Registered
2022-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: ââ?¬Å?COMPARISON BETWEEN PROPOFOL 3MG/KG AND ETOMIDATE 0.3MG/KG AS AN INDUCTION AGENT TO EVALUATE HEMODYNAMIC RESPONSE TO LARYNGOSCOPY AND ENDOTRACHEAL INTUBATIONââ?¬?: "TWO INTRAVEN

Sponsors

CIVIL HOSPITALGOVERNMENT OF GUJARAT
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1,2,3 PATIENTS POSTED FOR GENERAL SURGERY FOR SURGERY UNDER GENERAL ANESTHESIA REQUIRING ENDOTRACHEAL INTUBATION

Exclusion criteria

Exclusion criteria: Refusal to give consent Age ASA grade IV - V Known allergies to anaesthetic drugs Patients hemodynamically or neurologically unstable Patient having neurological or psychiatric disorder

Design outcomes

Primary

MeasureTime frame
EVALUATION OF PROPOFOL VS ETOMIDATE AS AN INDUCTION AGENT TO HEMODYNAMIC RESPONSE TO LARYNGOSCOPY AND ENDOTRACHEAL INTUBATION.Timepoint: FROM THE TIME OF INDUCTION TO 30 MIN POST ENDOTRACHEAL INTUBATION—

Secondary

MeasureTime frame
CHANGES IN INTRA-OPERATIVE HEMODYNAMIC CHANGES ANY COMPLICATIONS LIKE APNEA, MYOCLONUSTimepoint: FROM THE TIME OF INDUCTION TO 30 MIN POST ENDOTRACHEAL INTUBATION—

Countries

India

Contacts

Public ContactDR S J GOSWAMI

B.J. MEDICAL COLLEGE AND CIVIL HOSPITAL AHMEDABAD

dhrumit09@yahoo.com9327021192

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026